|1.||Horvath, F: 2 articles (01/2006 - 06/2005)|
|2.||Ramm, S: 2 articles (01/2006 - 06/2005)|
|3.||Pongratz, D: 2 articles (01/2006 - 06/2005)|
|4.||Stamenova, P: 2 articles (01/2006 - 06/2005)|
|5.||Koytchev, R: 2 articles (01/2006 - 06/2005)|
|6.||Kuhn, K: 2 articles (01/2006 - 06/2005)|
|7.||Svensson, Peter: 2 articles (01/2003 - 01/2003)|
|8.||Arendt-Nielsen, Lars: 2 articles (01/2003 - 01/2003)|
|9.||Kupferschmidt, Hugo: 1 article (06/2015)|
|10.||Schenk-Jaeger, Katharina M: 1 article (06/2015)|
10/01/1996 - "As a conclusion tolperisone hydrochloride represents an effective and safe treatment of painful reflex muscle spasm without the typical side effects of centrally active muscle relaxants."
01/01/2011 - "Prospective, open-labelled, non-comparative, multi-centre observational, Post Marketing surveillance study conducted at 174 participating orthopaedic care centres across India Nine hundred and twenty adult patients having painful muscle spasm associated with degenerative or inflammatory conditions were enrolled who received tolperisone 150 mg thrice daily orally for 7 days. "
01/01/2011 - "A phase IV observational multi-centre, open-label study on efficacy and safety of tolperisone 150 mg in patients with painful muscle spasm associated with degenerative or inflammatory diseases of the musculoskeletal system."
10/01/1996 - "Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial."
01/01/2011 - "Tolperisone is a safe, effective and non sedative alternative in management of acute painful spasm conditions associated with degenerative or inflammatory diseases of the musculoskeletal system. "
06/01/2012 - "The improvement in pain score at rest and on movement was significantly greater with Tolperisone ((p) = 0.0001). "
01/01/2003 - "In conclusion, tolperisone hydrochloride provides a small, albeit significant reduction in the perceived intensity of experimental jaw-muscle pain whereas the present dose had no effect on the short-latency jaw-stretch reflex."
10/01/2013 - "Tolperisone did not exert any visible effect on resting brain, but strongly inhibited the paw stimulation evoked BOLD responses, showing somewhat higher efficacy in brain areas involved in pain sensation. "
06/28/2003 - "All patients were middle-aged women who took tolperisone for chronic muscular pain. "
01/01/2003 - "The results suggest, that the prophylactic intake of tolperisone hydrochloride provides no relief to pain in course of post-exercise muscle soreness but results in reduction in isometric force."
|3.||Muscle Cramp (Cramp)
07/30/2013 - "[Effectiveness and safety of tolperisone in spasticity following cerebral stroke: randomized, double-blind, placebo-controlled trial]."
01/01/2008 - "The results of the study revealed that tolperisone was the most efficient in the treatment of post-stroke patients with spasticity. "
01/01/2006 - "To study the efficacy and safety of tolperisone--a centrally acting muscle relaxant with membrane stabilizing activity--in the treatment of stroke-related spasticity. "
01/01/2006 - "[A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke]."
06/01/2005 - "To study the efficacy and safety of tolperisone - a centrally acting muscle relaxant with membrane stabilizing activity - in the treatment of stroke-related spasticity. "
|5.||Muscle Spasticity (Spastic)
04/01/1997 - "When objectively assessed spastic muscle tone in the abductors, stiffness of Achilles and spontaneous ankle clonus were significantly reduced in tolperisone HCL group (P values = 0.001, 0.04, and 0.0001, respectively). "
01/01/1961 - "[Mydocalm, a new drug to relax spastic muscles in neurological diseases]."
01/01/2006 - "The findings of the present study demonstrate the efficacy and excellent tolerance of tolperisone in the treatment of spastic hypertonia following cerebral stroke. "
06/01/2005 - "The findings of the present study demonstrate the efficacy and excellent tolerance of tolperisone in the treatment of spastic hypertonia following cerebral stroke. "
11/01/1966 - "[Treatment of spastic paralysis after neurosurgery with the preparation "Mydocalm"]."
|3.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|4.||Protein Isoforms (Isoforms)
|5.||Sodium Channels (Sodium Channel)